Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-25-000032 General Corporate
Debt relative to revenue 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
217.85% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.61% · OPTIONAL · VALID
Operating cash generation 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.44% · OPTIONAL · VALID
Share-count growth 35th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.83% · CORE · VALID
Revenue growth 25th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-7.47% · CORE · VALID
Inventory pressure 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
46.24% · OPTIONAL · VALID
Gross margin 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
38.76% · CORE · VALID
Operating margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.06% · CORE · VALID
R&D intensity 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.16% · OPTIONAL · VALID
SBC intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.05% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 71.69%
Current 217.85%
Delta 146.17% Capex Intensity Increased
Previous 2.46%
Current 2.61%
Delta 0.15% Cash Generation Decreased
Previous 21.39%
Current 7.44%
Delta -13.95% Dilution Decreased
Previous -0.03%
Current -0.83%
Delta -0.80% Growth Increased
Previous -7.89%
Current -7.47%
Delta 0.42% Inventory Pressure Increased
Previous 11.99%
Current 46.24%
Delta 34.25% Margin Decreased
Previous 40.22%
Current 38.76%
Delta -1.46% Profitability Decreased
Previous 17.53%
Current 16.06%
Delta -1.47% R And D Intensity Decreased
Previous 2.20%
Current 2.16%
Delta -0.04% Sbc Intensity Increased
Previous 0.91%
Current 1.05%
Delta 0.14% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.